Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells

Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells

US Patent 10655144 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL s2025
Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL s2025
Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL s2025
Treating liver disease by selectively eliminating senescent cells2024
Treating liver disease by selectively eliminating senescent cells2024
Treating liver disease by selectively eliminating senescent cells2024
Treating cardiovascular disease by selectively eliminating senescent cells2024
Treating cardiovascular disease by selectively eliminating senescent cells2024
Treating cardiovascular disease by selectively eliminating senescent cells2024
Biomarkers for detecting senescent cells2023
Treating cognitive decline and other neurodegenerative conditions by selectively2022
Treating cognitive decline and other neurodegenerative conditions by selectively2022